SGLT2 inhibitor treatment in patients awaiting coronary artery bypass surgery to reduce post-operative atrial fibrillation and kidney injury - A randomized, prospective, multicenter clinical trial
We use cookies to keep your session secure, remember your preferences, and analyse site traffic with Google Analytics.
By continuing to use GrantFunds you agree to our
Privacy Policy
and
Terms of Use.